Approvals/TGA/LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 50mg/25mL Liposome Injection concentrate glass vial

Approved

STANDARD

LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 50mg/25mL Liposome Injection concentrate glass vial

Sun Pharma ANZ Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: def05d3a987a88d6
Product Name: LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 50mg/25mL Liposome Injection concentrate glass vial
Artg Id: 202827
Artg Name: LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 50mg/25mL Liposome Injection concentrate glass vial
Sponsor: Sun Pharma ANZ Pty Ltd
Company Detail Path: /organization/sun-pharma-anz-pty-ltd
Artg Date: 2013-12-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-02813-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-02812-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

def05d3a987a88d6

Type

Standard